MISSION

Our mission is to improve global health by advancing angiogenesis-based medicine, diet, and lifestyle.

 
 
“Imagine that one medical advancement holds the promise to conquer cancer and more than 70 of life’s most threatening conditions. This is the promise of angiogenesis.”
Dr. William Li
President and Medical Director
The Angiogenesis Foundation

GOALS

Our overarching goal is to help people worldwide lead longer, healthier lives.
To achieve this, we have three specific goals:

LS002302
ADVANCE
modern medicine by championing a new approach to conquering disease based on controlling angiogenesis
LS002302
IMPROVE
the lives of individuals who can benefit from angiogenesis treatments, on a global scale
LS002302
TRANSFORM
the way society views health and disease based on the principles of angiogenesis, in order to optimize public health

X
Patients
We leverage our third party position to create and disseminate multimedia learning tools that empower patients and their caregivers to better understand diseases and conditions related to angiogenesis and angiogenesis-based treatments.
Community Doctors
The Angiogenesis Foundation has a network of 40,000 physicians who stay informed about angiogenesis-based medicine through our CME programs and advocacy campaigns.
Regulators, Payers, Policymakers
The Angiogenesis Foundation actively collaborates with organizations and leaders from NIH, FDA, CMS, AHRQ, ASCO, AACR, Colorectal Cancer Alliance, Center for Medical Technology Policy, and Health Technology Assessment International, among other groups.
Clinical Investigators
We hold an annual high-level International Conference on Antiangiogenesis, supported by the Foundation’s continuously maintained knowledge library of major scientific and clinical developments in the angiogenesis field, the largest in the world.
Biotech/Pharma Industry
The Angiogenesis Foundation has, to date, successfully completed 512 industry collaborations with 165 companies to: establish awareness about specific diseases and unmet needs; discuss the data supporting the value of emerging validated treatments; identify methods to optimize care pathways.
Financial Community
Scientists
We convene national and international expert panels comprised of multiple stakeholders (scientists, investigators, association leaders, technology assessors, government representatives, payers, and health policy experts) to roadmap issues, challenges, and key solutions to improve patient outcomes, resulting in white paper recommendations.
Media
Channels used to reach audiences include: television broadcast (The Dr. Oz Show, the Martha Stewart show), the TED website and broadcasts, satellite radio, and print media including the New York Times, the Wall Street Journal, USA Today, Women’s Health, and Oprah Magazine. Finally, the foundation uses interactive campaign websites, Facebook, Twitter, Pinterest, and YouTube to connect with our audiences.